alexa A Successful Case of Persistent Asthma in the Treatment
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

A Successful Case of Persistent Asthma in the Treatment of Inhalation Corticosteroid Combination Therapy of Budesonide/Folmoterol and Ciclesonide

Nobuhiro Asai*, Yoshihiro Ohkuni and Norihiro Kaneko
Department of Pulmonology, Kameda Medical Center, Chiba, Japan
Corresponding Author : Nobuhiro Asai
Department of pulmonology
Kameda Medical Center, Zip296-8602
929 higashi-cho, Kamogawa-city
Chiba, Japan
Tel: 81-4-7092-2211
Fax: 81-4-7099-1198
E-mail: [email protected]
Received August 15, 2013; Accepted August 28, 2013; Published September 02, 2013
Citation: Asai N, Ohkuni Y, Kaneko N (2013) A Successful Case of Persistent Asthma in the Treatment of Inhalation Corticosteroid Combination Therapy of Budesonide/Folmoterol and Ciclesonide. J Clin Case Rep 3:296. doi:10.4172/2165-7920.1000296
Copyright: © 2013 Asai N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


A-60 years old woman has been observed in our outpatient clinic for several years. She has been uncontrolled for her asthma despite multi-drug therapy; [Fluticazone (FP) 800 μg/day+Salmeterol(SM l00 μg+Montelukast 10 mg+Theophilline 200 mg/day], presenting asthma control test (ACT) score as 13. We added Ciclesonide (CIC) to her therapy and replaced FP and SM with BFC. As a result, her pulmonary function and ACT score improved. The counts of eosinophils in induced sputum decreased significantly. Furthermore, during an observation period of 9 months, she had neither had an emergency visit nor an asthma exacerbation. While some physicians previously reported efficacy of Inhaled corticosteroids (ICS) combination therapy of FP and Beclomethasone (BDP), there are no reports concerning the efficacy and tolerability of ICS combination therapy of Budesonide/Folmoterol combination (BFC) and Ciclesonide-hydrofluoroalkane (CIC-HFA). This is the first case report of a persistent asthma patient succesfully treated by the ICS combination therapy of BFC and CIC-HFA.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version